Try GARD – Genomic Allergen Rapid Detection. The most accurate and informative in vitro skin and respiratory sensitization test for:

  • Screening of pharmaceutical candidates
  • Safety assessment of chemicals
  • Safety assessment of cosmetic ingredients

SenzaGen is specializing in genomics-based methodology for immunotoxicological assays. Our proprietary lead product, GARD, utilizes genomic biomarker signatures of hundreds of genes relevant for hazard prediction.

Doing so, it predicts and classifies chemical sensitizers with a state-of-the-art predictive performance.